Perforin expression by CD4+ regulatory T cells increases at multiple sclerosis relapse: Sex differences

International Journal of Molecular Sciences

Volumn 13, Issue 6, 2012, Pages 6698-6710

  Tejera Alhambra, Marta ^a   Alonso, Bárbara ^a   Teijeiro, Roseta ^a   Ramos Medina, Rocío ^a   Aristimuño, Carol ^a   Valor, Larissa ^a   de Andrés, Clara ^a   Sánchez Ramón, Silvia ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Cerebrospinal fluid; Multiple sclerosis; Perforin expression; Regulatory T lymphocytes

Indexed keywords

ALPHA INTERFERON; ESTRADIOL; INTERLEUKIN 2; PERFORIN; IL2 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL FUNCTION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; INCIDENCE; MALE; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SEX DIFFERENCE; BLOOD; CYTOLOGY; GENE EXPRESSION REGULATION; MIDDLE AGED; RECURRENT DISEASE; YOUNG ADULT;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-2; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PERFORIN; RECURRENCE; SEX FACTORS; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84862491810     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13066698     Document Type: Article

References (28)

1. McFarlin, D.E.; McFarland, H.F. Multiple sclerosis (second of two parts). N. Engl. J. Med. 1982, 307, 1246-1251.
2. Cvetanovich, G.L.; Hafler, D.A. Human regulatory T cells in autoimmune diseases. Curr. Opin. Immunol. 2010, 22, 753-760.
3. De Andres, C.; Aristimuno, C.; de Las Heras, V.; Martinez-Gines, M.L.; Bartolome, M.; Arroyo, R.; Navarro, J.; Gimenez-Roldan, S.; Fernandez-Cruz, E.; Sanchez-Ramon, S. Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis. J. Neuroimmunol. 2007, 182, 204-211.
4. Haas, J.; Hug, A.; Viehover, A.; Fritzsching, B.; Falk, C.S.; Filser, A.; Vetter, T.; Milkova, L.; Korporal, M.; Fritz, B.; et al. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 2005, 35, 3343-3352.
5. Viglietta, V.; Baecher-Allan, C.; Weiner, H.L.; Hafler, D.A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004, 199, 971-979.
6. Maggi, E.; Cosmi, L.; Liotta, F.; Romagnani, P.; Romagnani, S.; Annunziato, F. Thymic regulatory T cells. Autoimmun. Rev. 2005, 4, 579-586.
7. Baecher-Allan, C.; Viglietta, V.; Hafler, D.A. Human CD4+CD25+ regulatory T cells. Semin. Immunol. 2004, 16, 89-98.
8. Green, D.R.; Flood, P.M.; Gershon, R.K. Immunoregulatory T-cell pathways. Annu. Rev. Immunol. 1983, 1, 439-463.
9. Cosmi, L.; Liotta, F.; Lazzeri, E.; Francalanci, M.; Angeli, R.; Mazzinghi, B.; Santarlasci, V.; Manetti, R.; Vanini, V.; Romagnani, P.; et al.Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 2003, 102, 4107-4114.
10. Vlad, G.; Suciu-Foca, N., Resurgence or emergence of CD8+ Ts. Hum. Immunol. 2008, 69, 679-680.
11. Aristimuno, C.; de Andres, C.; Bartolome, M.; de las Heras, V.; Martinez-Gines, M.L.; Arroyo, R.; Fernandez-Cruz, E.; Sanchez-Ramon, S. IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year study. Clin. Immunol. 2009, 134, 148-157.
12. Aristimuño, C.; Navarro, J.; de Andres, C.; Martinez-Gines, L.; Gimenez-Roldan, S.; Fernandez-Cruz, E.; Sanchez-Ramon, S. Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after i.v. methyl-prednisolone for multiple sclerosis relapse. J. Neuroimmunol. 2008, 204, 131-135.
13. Tennakoon, D.K.; Mehta, R.S.; Ortega, S.B.; Bhoj, V.; Racke, M.K.; Karandikar, N.J. Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis. J. Immunol. 2006, 176, 7119-7129.
14. Feger, U.; Luther, C.; Poeschel, S.; Melms, A.; Tolosa, E.; Wiendl, H. Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin. Exp. Immunol. 2007, 147, 412-418.
15. Fritzsching, B.; Haas, J.; Konig, F.; Kunz, P.; Fritzsching, E.; Poschl, J.; Krammer, P.H.; Bruck, W.; Suri-Payer, E.; Wildemann, B. Intracerebral human regulatory T cells: Analysis of CD4+ CD25+ FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients. PLoS One 2011, 6, doi:10.1371/journal.pone.0017988.
16. Correale, J.; Villa, A. Role of CD8+ CD25+ Foxp3 regulatory T cells in multiple sclerosis. Ann. Neurol. 2010, 67, 625-638.
17. Valor, L.; Teijeiro, R.; Aristimuno, C.; Faure, F.; Alonso, B.; de Andres, C.; Tejera, M.; Lopez-Lazareno, N.; Fernandez-Cruz, E.; Sanchez-Ramon, S. Estradiol-dependent perforin expression by human regulatory T-cells. Eur. J. Clin. Invest. 2010, 41, 357-364.
18. Grossman, W.J.; Verbsky, J.W.; Barchet, W.; Colonna, M.; Atkinson, J.P.; Ley, T.J. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004, 21, 589-601.
19. McCombe, P.A.; Greer, J.M.; Mackay, I.R. Sexual dimorphism in autoimmune disease. Curr. Mol. Med. 2009, 9, 1058-1079.
20. Sanchez-Ramon, S.; Navarro, A.J.; Aristimuno, C.; Rodriguez-Mahou, M.; Bellon, J.M.; Fernandez-Cruz, E.; de Andres, C. Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity. Immunol. Lett. 2005, 96, 195-201.
21. Venken, K.; Hellings, N.; Thewissen, M.; Somers, V.; Hensen, K.; Rummens, J.L.; Medaer, R.; Hupperts, R.; Stinissen, P. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 2008, 123, 79-89.
22. Boissonnas, A.; Scholer-Dahirel, A.; Simon-Blancal, V.; Pace, L.; Valet, F.; Kissenpfennig, A.; Sparwasser, T.; Malissen, B.; Fetler, L.; Amigorena, S. Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes. Immunity 2010, 32, 266-278.
23. Beeston, T.; Smith, T.R.; Maricic, I.; Tang, X.; Kumar, V. Involvement of IFN-γ and perforin, but not Fas/FasL interactions in regulatory T cell-mediated suppression of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2010, 229, 91-97.
24. Cappellano, G.; Orilieri, E.; Comi, C.; Chiocchetti, A.; Bocca, S.; Boggio, E.; Bernardone, I.S.; Cometa, A.; Clementi, R.; Barizzone, N.; et al. Variations of the perforin gene in patients with multiple sclerosis. Genes. Immun. 2008, 9, 438-444.
25. Camiña-Tato, M.; Morcillo-Suarez, C.; Bustamante, M.F.; Ortega, I.; Navarro, A.; Muntasell, A.; Lopez-Botet, M.; Sanchez, A.; Carmona, P.; Julia, E.; et al. Gender-associated differences of perforin polymorphisms in the susceptibility to multiple sclerosis. J. Immunol. 2010, 185, 5392-5404.
26. Lenschow, D.J.; Walunas, T.L.; Bluestone, J.A., CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996, 14, 233-258.
27. Aristimuno, C.; Teijeiro, R.; Valor, L.; Alonso, B.; Tejera-Alhambra, M.; de Andres, C.; Minarro, D.O.; Lopez-Lazareno, N.; Faure, F.; Sanchez-Ramon, S. Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosis. Clin. Exp. Med. 2012, doi:10.1007/s10238-011-0172-3.
28. Berghofer, B.; Frommer, T.; Haley, G.; Fink, L.; Bein, G.; Hackstein, H. TLR7 ligands induce higher IFN-alpha production in females. J. Immunol. 2006, 177, 2088-2096.